SUL-151 Decreases Airway Neutrophilia as a Prophylactic and Therapeutic Treatment in Mice after Cigarette Smoke Exposure

Keyphrases

• Therapeutic Treatment 100%
• Cigarette Smoking 100%
• Cigarette Smoke Exposure 100%
• Prophylactic Treatment 100%
• Airway Neutrophilia 100%
• Neutrophils 40%
• Budesonide 40%
• Bronchoalveolar Lavage Fluid 40%
• Inflammation Model 40%
• Lung Homogenate 40%
• Mitochondrial DNA 20%
• Lung 20%
• Chronic Obstructive Pulmonary Disease 20%
• Oxidative Stress 20%
• Immune Cells 20%
• Protein Kinase 20%
• Glucocorticoid Therapy 20%
• Adenosine Triphosphate 20%
• Chronic Inflammation 20%
• Pulmonary Inflammation 20%
• Treatment Setting 20%
• Mitochondrial Dysfunction 20%
• Oropharyngeal 20%
• Oxidative Stress Response 20%
• Mitophagy 20%
• Chronic Obstructive Pulmonary Disease Treatment 20%
• Radical Scavenging Activity 20%
• Adenosine Triphosphate Production 20%
• Mitoprotective 20%
• Malondialdehyde Level 20%

Immunology and Microbiology

• Lung Homogenate 100%
• Bronchoalveolar Lavage Fluid 100%
• Oxidative Stress 100%
• Neutrophil 100%
• Budesonide 100%
• Airway 100%
• Pulmonary Inflammation 50%
• Immunocompetent Cell 50%
• Mitophagy 50%
• Glucocorticoid 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Cigarette Smoke 100%
• Neutrophilia 100%
• Chronic Obstructive Lung Disease 33%
• Budesonide 33%
• Inflammation 33%
• Adenosine Triphosphate 33%
• Glucocorticoid 16%
• Chronic Inflammation 16%
• Malonaldehyde 16%
• Protein Kinases 16%
• Combination Therapy 16%
• Pneumonia 16%
• Mitochondrial DNA 16%